CRT 2016 Coronary - The Thrombin Inhibitors Great Debate: Bivailrudin vs. Heparin

Conference
The Thrombin Inhibitors Great Debate: Bivailrudin vs. Heparin at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview


CRT 2016 - The Thrombin Inhibitors Great Debate: Bivailrudin vs. Heparin Session

Session Moderators & Panelists: George Dangas, MD, FSCAI; David Moliterno, MD, FSCAI; Jeffrey Berger, MD, MS

2 Expert Debates

Featuring

  • George Dangas, MD, FSCAI
  • David Moliterno, MD, FSCAI
  • Jeffrey Berger, MD, MS
  • Gregg Stone, MD, FSCAI
  • A. Michael Lincoff, MD
  • Paul Gurbel, MD, FSCAI
  • Sanjit Jolly, MD, MSc
  • Neal Kleiman, MD, FSCAI
  • Michael Lipinski, MD, PhD, FSCAI

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.



Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: The Thrombin Inhibitors Great Debate: Bivailrudin vs. Heparin

Track: Coronary

Learning Objectives

  • Update in advances in ACS & AMI Management

Loading Simple Education